Nanotech platform Carries mRNA Directly to Target Cells | NextBigFuture.com

A new study explores a biological approach to directing nanocarriers loaded with protein “game changers” to specific cells. The groundbreaking method may prove useful in treating myriad malignancies, inflammatory diseases and rare genetic disorders. Lipid nanoparticles (LNP) were used to deliver modified messenger RNA to treat inflammatory bowel diseases and other diseases. Prof. Dan Peer, Molecular Cell Biology at TAU’s Faculty of Life Sciences, led the research for the new study. Nature Communications – Cell-specific delivery of modified mRNA expressing therapeutic proteins to leukocytes Over the past few years, lipid carriers encapsulating messenger RNAs (mRNAs) have been shown to be The post Nanotech platform Carries mRNA Directly to Target Cells appeared first on NextBigFuture.com.